Assessment of In vivo siRNA delivery in cancer mouse models

Research output: Chapter in Book/Report/Conference proceedingChapter

9 Scopus citations

Abstract

RNA interference (RNAi) has rapidly become a powerful tool for target discovery and therapeutics. Small interfering RNAs (siRNAs) are highly effective in mediating sequence-specific gene silencing. However, the major obstacle for using siRNAs as cancer therapeutics is their systemic delivery from the administration site to target cells in vivo. This chapter describes approaches to deliver siRNA effectively for cancer treatment and discusses in detail the current methods to assess pharmacokinetics and biodistribution of siRNAs in vivo.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages189-197
Number of pages9
DOIs
StatePublished - Jan 1 2016

Publication series

NameMethods in Molecular Biology
Volume1402
ISSN (Print)1064-3745

Keywords

  • Cancer therapy
  • Delivery
  • Ovarian cancer
  • Stem-loop RT-PCR
  • siRNA

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Fingerprint

Dive into the research topics of 'Assessment of In vivo siRNA delivery in cancer mouse models'. Together they form a unique fingerprint.

Cite this